Skip to content

Conversation With Family Doctor to Increase COVID-19 Vaccine Uptake

[In Norwegian]: Samtale Med Fastlegen Som Tiltak for å øke Covid-19-vaksinedekningen

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05207137
Enrollment
654
Registered
2022-01-26
Start date
2021-12-03
Completion date
2022-06-30
Last updated
2025-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Keywords

Health services research, Quality improvement

Brief summary

The investigators will randomise individuals from family doctors' lists of patients that are at risk of severe Coronavirus Disease 2019 (COVID-19), and that are not registered as having taken the vaccine against the disease. The patients will be randomised to receiving a phone call from their family physician where the participants are given the opportunity to raise questions they might have around vaccination. The investigators will assess whether this has an impact on vaccine uptake.

Interventions

BEHAVIORALTelephone call about vaccination

Participants receive phone call from their family physician, where they are invited to ask questions about the COVID-19 vaccine.

Sponsors

Norwegian Institute of Public Health
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

Randomized trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Belonging to group at risk of severe COVID-19

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Vaccination status (COVID-19)3-6 weeks after inclusionChange in proportion of participants who are registered in the national vaccination registry, as having received at least one dose of a COVID-19 vaccine.

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026